Benta Pharma Industries, known as BPI, started in 2006 and works from Zouk El Khrab in Dbayeh, where it runs two manufacturing facilities. What sets it apart from most Lebanese drug makers is that it produces both medicines and sterile medical devices. On the pharmaceutical side it covers cardiovascular, central nervous system, diabetes, dermatology, urology, transplant and anesthesia treatments, along with oncology and sterile products; a recent launch is Rixalta, a generic of the blood thinner rivaroxaban. Its device range includes items for anesthesia, urology, surgery, cardiovascular care and IV administration, plus ophthalmic products such as intraocular lenses. The devices carry CE marking and the company holds ISO 13485 and ISO 9001. BPI reports more than 250 employees and over 200 products, and licensing partners have included CSL Behring, Mylan, Sanofi and Zentiva.
Benta Pharma Industries (BPI) at a glance
- Founded in 2006, with two manufacturing facilities
- Makes CE-marked sterile medical devices, including intraocular lenses
- Reports 250+ employees and 200+ products
- Present in more than 40 countries
- Holds GMP, ISO 9001 and ISO 13485 certifications